add share buttonsSoftshare button powered by web designing, website development company in India

Zantac Lawsuits After Experiencing Bladder & Stomach Cancer

Zantac, a popular heartburn medicine that was safe enough to be sold over-the-counter, has been found to contain unsafe levels of a chemical known as a cancer-causing agent. The makers of Zantac (ranitidine) are now experiencing a product liability lawsuit that alleges the drug contains N-Nitrosodimethylamine (NDMA), which is a chemical classified as a probable carcinogen by the Food and Drug Administration (FDA), World Health Organization, and Environmental Protection Agency.

The makers of the popular anti-inflammatories are accused of marketing and manufacturing a drug that contains a cancer-causing chemical. They failed to warn consumers or the government about the risks. The personal injury lawyers at www.zantacantacidcancerlawsuit.com/stomach-cancer-lawsuits.asp can help you learn more about Zantac.

How to prepare an effective study plan for judiciary preparation : secrets that toppers and coaching classes won't tell you (webinar brief) - iPleaders

Image Source: Google

Who's at Risk?

Recent testing has shown that Zantac (ranitidine), can cause high levels of NDMA in those who take the drug. Studies have also shown that the medication's unstable molecules can be broken down in the stomach to produce dangerous levels of NDMA. Zantac (ranitidine), is not recommended for long-term use. However, it can only cause cancer if taken in high doses over a prolonged period.

How do you determine if your case is eligible for a Zantac Cancer Lawsuit?

You must prove that you used Zantac in order to be eligible for a Zantac lawsuit. To prove that Zantac was prescribed by your doctor, you can request a copy of your pharmacy records. The receipts and notes from your medical records can be used to prove that Zantac was purchased over-the-counter. After you have obtained proof of medication, you will need to prove that you suffered an injury due to taking the medication.